Treatment With a Soluble Bone Morphogenetic Protein Type 1A Receptor (BMPR1A) Fusion Protein Increases Bone Mass and Bone Formation in Mice Subjected to Hindlimb Unloading.

Ko, Frank C; Van Vliet, Miranda; Ellman, Rachel; Grasso, Daniel; Brooks, Daniel J; Spatz, Jordan M; Conlon, Chrissy; Aguirre, J Ignacio; Wronski, Thomas J; Bouxsein, Mary L

Ko, Frank C; Van Vliet, Miranda; Ellman, Rachel; Grasso, Daniel; Brooks, Daniel J; Spatz, Jordan M; Conlon, Chrissy; Aguirre, J Ignacio; Wronski, Thomas J; Bouxsein, Mary L.

Afiliación

Ko FC; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.
Van Vliet M; Endocrine Unit Massachusetts General Hospital Boston MA USA.
Ellman R; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.
Grasso D; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.
Brooks DJ; Massachusetts Institute of Technology (MIT) Health Sciences and Technology Program Cambridge MA USA.
Spatz JM; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.
Conlon C; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.
Aguirre JI; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.
Wronski TJ; Massachusetts Institute of Technology (MIT) Health Sciences and Technology Program Cambridge MA USA.
Bouxsein ML; Center for Advanced Orthopedic Studies Beth Israel Deaconess Medical Center Boston MA USA.